ASK REDCHAT ANYTHING ABOUT ALIGOS THERAPEUTICS INC.
Aligos Therapeutics Inc. (NASDAQ: ALGS)
Listen to this Section
$4.96
-0.3850
(
-7.21% )
70.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ALG-097558DetailsCOVID-19 |
Phase 2 |
| ALG-000184 (Capsid Assembly modulator)DetailsChronic hepatitis B |
Phase 1 |
| ALG-010133 (S-antigen Transport-inhibiting Oligonucleotide Polymer)DetailsChronic hepatitis B |
Failed |
| ALG-125755DetailsChronic hepatitis B, Liver disease |
Failed |
Market Data
|
| Open |
$4.96 |
| Previous Close |
$5.34 |
| Volume |
70.8K |
| Market Cap |
$31.81M |
| Day Range |
$4.86 - $5.41 |
| 52 Week Range |
$4.86 - $13.69 |
| Shares Outstanding |
6.19M |
| Change % |
-7.21% |
| Net Change |
▼ -0.3850 |
| Insider Ownership |
-0.04% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
3,713,003.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-09 |
Sale |
-120000.00 |
Preston Heather |
| 2024-08-09 |
Sale |
-120000.00 |
Chavez Margarita |
| 2024-06-28 |
Sale |
-60000.00 |
Hirth Peter |
| 2024-06-28 |
Sale |
-60000.00 |
Scopa James Paul |
| 2024-06-28 |
Sale |
-60000.00 |
Martell Bridget A |
| 2024-06-28 |
Sale |
-60000.00 |
Nuechterlein Carole |
| 2024-03-04 |
Sale |
-72000.00 |
McClure Matthew W. |
| 2024-03-04 |
Sale |
-72000.00 |
Symons Julian A. |
| 2024-03-04 |
Sale |
-308940.00 |
Calhoun Lesley Ann |
| 2024-03-04 |
Sale |
-965435.00 |
BLATT LAWRENCE |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
12 |
Feb 04, 2026 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
66 |
Nov 06, 2025 |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| schedule |
Other |
1 |
Aug 14, 2025 |
| schedule |
Other |
1 |
Aug 13, 2025 |
| schedule |
Other |
1 |
Aug 12, 2025 |
| s-8 |
Registration statements |
16 |
Aug 06, 2025 |
| 8-k |
8K-related |
14 |
Aug 06, 2025 |
| 10-q |
Quarterly Reports |
69 |
Aug 06, 2025 |